Zebeta (Bisoprolol)

Do’s

• Zebeta is typically taken orally, with or without food, as directed by a healthcare provider, usually once a day. The specific dosage is determined based on the individual's medical condition and their response to treatment.
• Consistent and regular use of this medication is crucial to derive the most benefit from it. To aid in remembering, take Zebeta at the same time each day.
• It may take several weeks before the full benefit of this drug is realized. Continue taking this medication even if feeling well, as many individuals with high blood pressure do not experience noticeable symptoms.
• If there is no improvement in the condition or if it worsens (for example, if blood pressure readings remain high or increase), communicate this to your healthcare provider.

Common Side Effects:

• Transaminase elevations
• Creatinine and BUN level increases
• Febrile seizures in children

Not all individuals may experience these side effects, and they may not occur in everyone who takes Zebeta.

Serious Side Effects:

• Chest pain
• Heart attack
• Irregular heartbeat
• Worsening of bronchospastic disease (such as asthma or COPD)

Seek medical attention if you experience any of these serious side effects while taking Zebeta.

This is not an exhaustive list of potential side effects of Zebeta. Always consult your healthcare provider for personalized medical advice and guidance.

Do not stop taking Zebeta without consulting a healthcare provider. Abruptly stopping the medication can lead to worsening of certain conditions, such as chest pain, heart attack, and irregular heartbeat. If a healthcare provider decides that the medication should be discontinued, they may direct a gradual decrease in the dose over 1 to 2 weeks.

It is generally not necessary to adjust the dose in the elderly unless there is significant renal or hepatic dysfunction. However, there is no pediatric experience with Zebeta, so its use in pediatric patients should be carefully considered.

Patients with bronchospastic disease should generally not receive beta-blockers. However, due to its relative beta1-selectivity, Zebeta may be used with caution in patients with bronchospastic disease who do not respond to or cannot tolerate other antihypertensive treatments.

Beta-blocking agents should be avoided in patients with overt congestive heart failure. However, in some patients with compensated cardiac failure, it may be necessary to utilize them cautiously. Continued depression of the myocardium with beta-blockers can, in some patients, precipitate cardiac failure. Therefore, at the first signs or symptoms of heart failure, discontinuation of Zebeta should be considered.

Zebeta may interact with other medications. Discuss all current medications with a healthcare provider to avoid potential interactions.

This is not an exhaustive list of warnings and precautions for Zebeta. Always consult a healthcare provider for personalized medical advice and guidance.